Who we help / Health systems & cancer centers
Move more advanced therapy cases to outpatient delivery
Current Health gives your program early toxicity detection, 24/7 nurse coverage, and ready-to-run models for CAR-T, bispecifics, and other advanced therapies. Treat more patients safely outside the hospital, free inpatient beds for the patients who need them, and scale your program.
1,500+
advanced therapy episodes
90%
of CAR-T patients made eligible for outpatient care at Sarah Cannon
80%
of patient issues resolved without site escalation
60
peer-reviewed papers and abstracts
The challenges we help solve
What keeps advanced therapy programs from scaling?
Indications and eligible populations keep growing, while bed capacity and overnight staffing stay fixed. In an inpatient model, programs end up limiting access by bed count.
Beds that cap how many patients you treat
Post-infusion monitoring occupies high-acuity beds, so referrals wait for a free bed. Moving monitoring home frees those beds for other patients who need acute care.
12–16
inpatient bed days avoided per CAR-T patient
6–7
inpatient bed days avoided per bispecific patient
An inpatient bed is the most expensive place to watch a patient
Much of a post-infusion stay is spent watching for toxicity, not treating it. Moving that monitoring out of an inpatient bed can lower your cost to serve and lets you backfill the bed with another patient who needs acute care.
“The cost savings from keeping these people outpatient … and being able to backfill our beds has made the cost of Current Health’s support somewhat insignificant.”
Tricia Estacio, RN, Director of Nursing, UCSF Health
Running an outpatient program is a second job
Overnight triage, patient and caregiver education, protocols, device logistics, and quality reporting all land on a team that already has a full day. Current Health takes that work on, from 24/7 nursing and kit logistics to program launch, so your clinicians can focus on treatment decisions.
55%
of clinical alerts occur in the 8 overnight hours
Referrals limited to patients who live nearby
Patients far from the center are harder to treat outpatient. Early detection and coordinated escalation let you widen your radius and accept more of the referrals you want.
40%
less likely to receive CAR-T when patients live 2–4 hours from a treatment center
Ahmed et al., Transplant Cell Ther 2024
A proven model for each therapy
CAR-T and bispecifics carry different risks, so we built a model for each. Both come with evidence-based protocols, implementation handled by our team, and the same 24/7 Clinical Coordination Center. We also support TIL therapy and monoclonal antibodies, with the same 24/7 Clinical Coordination Center behind every patient.
Make outpatient the default for CAR-T
Most CAR-T programs still monitor patients inpatient. Our model pairs passive monitoring of multiple signals, patented CRS detection, and virtual ICANS assessments with 24/7 nurse coordination, so nearly every patient can go outpatient, including older and frail patients.
- Outpatient eligibility for nearly every patient
- Inpatient beds freed for other high-acuity patients
- Lower cost to serve and better reimbursement than inpatient
- An outcomes record for your payer and referral conversations
90%
of CAR-T patients made eligible for outpatient care at Sarah Cannon
Scale bispecific programs without scaling your staff
Bispecific programs are limited in scale during the step-up dosing period, when most toxicities present. We help get patients home sooner with lightweight check-ins and 24/7 nurse oversight, so your program can scale efficiently.
- Unplanned returns decided by your on-call, with direct admission to your unit arranged by our nurses
- Overnight calls handled by our nurses, who page your on-call when your criteria are met, with an SBAR summary
- Evidence-based protocols ready on day one
- Low cost and low lift, with no EHR integration required
4–6 wks
to go live, including platform configuration and training
Your network
Grow across your network, not just your main campus
Hub-and-spoke delivery
Give the infusion or step-up dose at your center, then support patients at home or near your network sites where each product's label and your protocol allow, with one Clinical Coordination Center, pathways configured to your protocols, and reporting by site and therapy.
The escalation partner for community programs
When community practices in your region deliver CAR-T or bispecifics with Current Health, escalation protocols are agreed with a hospital partner before the first patient. Escalations arrive at your ED or unit expected: our nurses call ahead so your team knows who is coming and why.
What’s behind every model
The same clinical layer behind every patient
Clinical coordination
Our nurses, drawn from ED and ICU, assess, escalate per your protocols, arrange transfers, start treatment under your standing orders, and document every interaction, around the clock.
2 min
to reach a patient or caregiver about an alarm
Toxicity detection
CRS, ICANS, and the infections, cardiac events, and other complications that send frail patients back to the hospital.
7 hrs
median earlier recognition of CRS than standard inpatient nursing care
Mount Sinai
Quality reporting
Program dashboards show toxicity, escalations, response times, rehospitalizations, and outcomes by site and therapy, and can blend in encounter data from your EHR. The outcomes record behind your FACT quality management plan and payer conversations.
Day one
reporting on our data, with EHR integration optional at go-live
Program results
Proven in leading cancer centers
Sarah Cannon Cancer Network1
75%
shorter stays for patients who needed admission
UCSF Health2
231
bed days saved across the first 23 patients
“Partnering with Current Health has allowed us to safely transition CAR-T to an outpatient setting, supporting patients beyond the hospital walls, without compromising safety, quality of care, or clinical oversight.”
Navneet Majhail, MD, FASTCT
Physician-in-Chief, Blood Cancers, Sarah Cannon Cancer Network
Why Current Health
Why health systems choose Current Health
Ready to run
Evidence-based protocols, platform setup, training, and kit logistics are handled by our team, so launching doesn’t fall on your staff.
The most experienced advanced therapy nurses
More than 20,000 advanced therapy patient monitoring days, by nurses drawn from ED and ICU, licensed in all 50 states.
Care for the whole patient
Experience managing frail, older patients at home, with 95.3% median wearable adherence in patients 75+ (Pugmire et al., Age and Ageing, 2024).
Trusted by leading cancer centers
Want to make advanced therapies more accessible to your patients?
We’ll help you find the right starting point, whether you’re scaling bispecific step-up dosing or moving CAR-T outpatient.